ArticleFunctional & integrative genomics2026
Biodegradation Characteristics of Piperacillin by Marine Bacillus cereus PP1 and Genome-Guided Mining of Candidate β-Lactamases.
Article in Functional & integrative genomics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Antibiotic residues in aquatic environments are an increasing concern because they may retain antibacterial activity, promote antibiotic resistance and generate transformation products with uncertain ecological risks. In this study, marine-derived bacteria were screened for their ability to degrade representative β-lactam antibiotics. Strain PP1, identified as Bacillus cereus, was selected for detailed characterization because of its outstanding degradation capacity toward piperacillin, ceftiofur and cephalexin, especially its efficient removal of piperacillin at a high initial concentration of 100 mg/L. During a 48-h incubation, B. cereus PP1 completely degraded piperacillin and reduced the antibacterial activity of the treated solution against representative Gram-negative and Gram-positive bacteria. UHPLC-MS/MS analysis indicated that piperacillin was transformed mainly through β-lactam ring opening, together with side-chain cleavage and downstream fragmentation reactions. The degradation products showed no obvious hemolytic activity under the tested conditions, whereas live PP1 exhibited hemolysis, highlighting the need for biosafety evaluation before live-cell application. Whole-genome sequencing revealed that PP1 contains a single circular chromosome of 5,285,738 bp and has broad metabolic potential. CARD, CAZy and VFDB annotations indicated antibiotic tolerance, hydrolytic enzyme resources and virulence-associated features. Targeted mining using a local β-lactamase database identified two candidate β-lactamase genes, PP1_BLA_A and PP1_BLA_B, assigned to class A and class B β-lactamases, respectively. Structure prediction and molecular docking further suggested that both enzymes can accommodate piperacillin, but with distinct binding modes. These findings indicate that B. cereus PP1 is a valuable source for β-lactamase discovery and enzyme-based β-lactam bioremediation.
Indexed as
Identifiers
42850472What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.